Skip to content

Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study

Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07402577
Enrollment
40
Registered
2026-02-11
Start date
2026-03-30
Completion date
2028-02-01
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Sarcoma of Soft Tissue, Sarcoma

Brief summary

This study generates information on the feasibility and acceptability of a 3-month ecological momentary assessment (EMA) protocol to assess chronic pain and opioid use in adolescent and young adult (AYA) sarcoma survivors.

Detailed description

PRIMARY OBJECTIVES: I. Evaluate the feasibility and acceptability of a 3-month EMA protocol in AYA sarcoma survivors. II. Quantify variability in pain and opioid use over a 3-month period for AYA sarcoma survivors. III. Identify associations between biopsychosocial mechanisms (e.g., pain beliefs, worry) and pain and opioid use outcomes. OUTLINE: This is an observational study. Patients complete baseline questionnaires, daily EMA surveys and an interview on study.

Interventions

Non intervention study

Sponsors

Roswell Park Cancer Institute
Lead SponsorOTHER
University at Buffalo
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* All genders between the ages of 12-24 (inclusive) at sarcoma diagnosis. * Any age \< 70 at the time of study enrollment. * No evidence of disease and/or enrolled in survivorship care. * Clinically meaningful pain related to disease or its treatments at baseline (defined as 3 or greater on a 0-10 Numerical Rating Scale). * Willing to attend the baseline appointment in person. * Access to internet-capable smartphone. * Access to internet on an occasional basis. * Willing and able to complete Ecological Momentary Assessments (EMAs) on internet-capable smartphone for a 3-month period after enrollment. * Ability to understand and provide informed consent/assent.

Exclusion criteria

* \* Currently receiving active cancer-directed therapy. * Unable to read or fluently speak English. * Determined by clinical staff to have preexisting or cancer-associated cognitive impairment that could interfere with study participation. * Acutely suicidal (e.g. intent or plan) or, with unstable medical or psychiatric condition verified by licensed study staff. * Characteristics related to inability to complete the study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of recruitmentUp to 12 monthsFeasibility of recruitment will be based on number eligible per medical record
Feasibility of assessmentUp to 12 monthswill be indexed by number completing 80% of EMA assessments
Reasons for nonparticipationUP to 12 monthsSemi structured qualitive interviews will focus on factors that influenced participation
Acceptability of EMA Study DesignUp to 12 monthsself-reported difficulty of participating in daily EMA surveys (0-19) .
Acceptability of EMA DesignUp to 12 monthsAcceptability of the protocol will be assessed by responses on the System Usability Scale - A 10 question scale from 1 to 5 with 1 being strongly disagree and 5 being strongly agree.

Countries

United States

Contacts

CONTACTAndrew Rogers
Andrew.Rogers@roswellpark.org1-800-767-9355
PRINCIPAL_INVESTIGATORAndrew Rogers

Roswell Park

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026